Composition pharmaceutique contenant de l'acétominophène et de l'ibuprofène
L'invention concerne des formes posologiques orales solides contenant 325 mg d'acétaminophène et 97,5 mg d'ibuprofène ou 500 mg d'acétaminophène et 150 mg d'ibuprofène, l'ibuprofène ayant un [d50] compris entre 1 et 9 µm. The invention is a solid oral dosage form, for e...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | French |
| Published |
31.10.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | L'invention concerne des formes posologiques orales solides contenant 325 mg d'acétaminophène et 97,5 mg d'ibuprofène ou 500 mg d'acétaminophène et 150 mg d'ibuprofène, l'ibuprofène ayant un [d50] compris entre 1 et 9 µm.
The invention is a solid oral dosage form, for example a tablet, comprising 325 mg of acetaminophen and 97.5 mg of ibuprofen, or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 2 and 8 µm, a [D10] between 1 and 3 µm, and a [D90] between 4 and 16 µm. |
|---|---|
| AbstractList | L'invention concerne des formes posologiques orales solides contenant 325 mg d'acétaminophène et 97,5 mg d'ibuprofène ou 500 mg d'acétaminophène et 150 mg d'ibuprofène, l'ibuprofène ayant un [d50] compris entre 1 et 9 µm.
The invention is a solid oral dosage form, for example a tablet, comprising 325 mg of acetaminophen and 97.5 mg of ibuprofen, or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 2 and 8 µm, a [D10] between 1 and 3 µm, and a [D90] between 4 and 16 µm. |
| Author | CALLAHAN, Matt MURPHY, Maura |
| Author_xml | – fullname: MURPHY, Maura – fullname: CALLAHAN, Matt |
| BookMark | eNrjYmDJy89L5WTwc87PLcgvzizJzM9TKMhILMpNTE4tLcksLE1VSM7PK0nNS8wrUUhJVchRT0w-vLIkPzczL78g4_CKvFSFVKhEZlJpQVF-GkiMh4E1LTGnOJUXSnMzyLm5hjh76KYW5MenFhcADc9LLYn3dTQ1MTCycDIyJqgAAA7ZOXE |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | MA54028B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_MA54028B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Oct 11 05:27:45 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_MA54028B23 |
| Notes | Application Number: MA20200054028 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231031&DB=EPODOC&CC=MA&NR=54028B2 |
| ParticipantIDs | epo_espacenet_MA54028B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20231031 |
| PublicationDateYYYYMMDD | 2023-10-31 |
| PublicationDate_xml | – month: 10 year: 2023 text: 20231031 day: 31 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | AFT PHARMACEUTICALS LIMITED |
| RelatedCompanies_xml | – name: AFT PHARMACEUTICALS LIMITED |
| Score | 3.3434358 |
| Snippet | L'invention concerne des formes posologiques orales solides contenant 325 mg d'acétaminophène et 97,5 mg d'ibuprofène ou 500 mg d'acétaminophène et 150 mg... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Composition pharmaceutique contenant de l'acétominophène et de l'ibuprofène |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231031&DB=EPODOC&locale=&CC=MA&NR=54028B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTZOSks2SLXQTQa2rXVN0lKNdC0NTE11Ey1NgFosDZLNU0EdRV8_M49QE68I0wgmhnTYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dgxorwELFxcnWNcDfxd9ZzdnZFlh0-QXZAhsmRhZOwLKaFdiGNget_XINcwJtSSlArk_cBBnYAoBG5ZUIMTClFQkzcDrDrl0TZuDwhc52A5nQjFcswuAHyrfQ9VUKBRnwcWhgqa4AWm2eClrPopCSqpCjnph8eGVJfm5mXn5BxuEVeakKqVCJzKRS0A3dIDFRBjk31xBnD12gw-LhQRDv6wj1gLEYA0tefl6qBINCCuiOIdPktLS0RCBtYZlkmGaebAFaI5WUaA7sJkgyiOMwRAqnjDQDFygUIYWzDANLSVFpqiyw1i1JkgOHGACluItg |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTZOSks2SLXQTQa2rXVN0lKNdC0NTE11Ey1NgFosDZLNU0EdRV8_M49QE68I0wgmhnTYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dgxorwELFxcnWNcDfxd9ZzdnZFlh0-QXZAhsmRhZOwLKaFdi-tgAdsu8a5gTaklKAXJ-4CTKwBQCNyisRYmBKKxJm4HSGXbsmzMDhC53tBjKhGa9YhMEPlG-h66sUCjLg49DAUl0BtNo8FbSeRSElVSFHPTH58MqS_NzMvPyCjMMr8lIVUqESmUmloBu6QWKiDHJuriHOHrpAh8XDgyDe1xHqAWMxBpa8_LxUCQaFFNAdQ6bJaWlpiUDawjLJMM082QK0Riop0RzYTZBkEMdhiBROGXkGTo8QX594H08_b2kGLlCIQgpqGQaWkqLSVFlgDVySJAcOPQBXU45Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Composition+pharmaceutique+contenant+de+l%27ac%C3%A9tominoph%C3%A8ne+et+de+l%27ibuprof%C3%A8ne&rft.inventor=MURPHY%2C+Maura&rft.inventor=CALLAHAN%2C+Matt&rft.date=2023-10-31&rft.externalDBID=B2&rft.externalDocID=MA54028B2 |